--- title: "Tumour Infiltrating Lymphocyte (TIL) Therapy hubs for Melanoma (Adults)" ocid: "ocds-h6vhtk-0515a8" canonical_url: "https://d3tenders.com/contract/?ocid=ocds-h6vhtk-0515a8" markdown_url: "https://d3tenders.com/contract/ocds-h6vhtk-0515a8.md" json_url: "https://d3tenders.com/contract/ocds-h6vhtk-0515a8.json" source: "Find A Tender Service" current_stage: "Tender" buyer: "NHS ENGLAND" published: "2025-07-08" --- # Tumour Infiltrating Lymphocyte (TIL) Therapy hubs for Melanoma (Adults) Buyer: NHS ENGLAND Current stage: Tender OCID: ocds-h6vhtk-0515a8 [View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-h6vhtk-0515a8) [Download OCDS JSON](https://d3tenders.com/contract/ocds-h6vhtk-0515a8.json) ## Summary NHS England initiated a tender process to establish Tumour Infiltrating Lymphocyte (TIL) Therapy hubs for melanoma treatment across England, targeting specific geographic regions. The procurement process was open, accommodating various submissions, but was ultimately abandoned on 30th June 2025, as announced by NHS England. Although the process did not result in a contract, significant emphasis was placed on health services, specifically the provision of cellular therapies for previously treated melanoma, aligning with NHS England's Specialised Commissioning goals. Interested parties were originally invited to submit bids by 12:00pm on 24th June 2025, which was later extended to 1st July 2025. This tendering opportunity, although abandoned, highlighted potential growth areas for businesses specialising in health services, particularly those with expertise in cellular therapies, surgical tissue resection, and care management of interleukin-2 inhibitor effects. Businesses equipped with appropriate Human Tissue Authority licences and working towards or holding JACIE Accreditation were particularly poised to compete effectively. While no contract was awarded, the initiative underscored NHS England's commitment to engaging experienced providers in advancing innovative treatments for melanoma, generating future opportunities as the service continues to develop in line with NICE guidance. ## Notice NHS Arden and Greater East Midlands Commissioning Support Unit (AGCSU), on behalf of NHS England -Specialised Commissioning (referred to as the Authority), is inviting suitably qualified and experienced providers to respond to this Competitive Process for the provision of Tumour Infiltrating Lymphocyte (TIL) Therapy hubs for Melanoma (Adults). As a result of this procurement exercise an agreement will be established with the successful bidder(s) for a period of three (3) years with the Commissioners having the option to extend for up to an additional two (2) year(s) (maximum contract duration 5 years). The deadline for submissions is 12.00pm (noon) on Tuesday 24th June 2025. ### Lot Information Lot 1 - London (2 Sites) The key objectives of the Procurement are to commission eight (8) Tumour Infiltrating Lymphocyte (TIL) Therapy Hubs for adult patients, for the provision of Lifileucel for previously treated unresectable or metastatic melanoma, with two (2) sites in London. Providers may only bid for one Lot. Bids submitted for multiple lots will not be considered. Bidders are to note that Providers must be located in and deliver services from the defined geographical area(s) that they are interested in providing services to. Link to NHS England Regions: NHS England " Regional teams (https://www.england.nhs.uk/about/regional-area-teams/). As a result of this procurement exercise an agreement will be established with the successful bidder(s) for a period of three (3) years with the Commissioners having the option to extend for up to an additional two (2) year(s) (maximum contract duration 5 years). The deadline for submissions is 12.00pm (noon) on Tuesday 24th June 2025. Options: Following the initial 3 year contract period, there is an option to extend for up to an additional 2 year(s) Lot 2 - East of England (1 Site) The key objectives of the Procurement are to commission eight (8) Tumour Infiltrating Lymphocyte (TIL) Therapy Hubs for adult patients, for the provision of Lifileucel for previously treated unresectable or metastatic melanoma, with one (1) site in the East of England. Providers may only bid for one Lot. Bids submitted for multiple lots will not be considered. Bidders are to note that Providers must be located in and deliver services from the defined geographical area(s) that they are interested in providing services to. Link to NHS England Regions: NHS England " Regional teams (https://www.england.nhs.uk/about/regional-area-teams/). As a result of this procurement exercise an agreement will be established with the successful bidder(s) for a period of three (3) years with the Commissioners having the option to extend for up to an additional two (2) year(s) (maximum contract duration 5 years). The deadline for submissions is 12.00pm (noon) on Tuesday 24th June 2025. Options: Following the initial 3 year contract period, there is an option to extend for up to an additional 2 year(s) Lot 3 - South East (1 Site) The key objectives of the Procurement are to commission eight (8) Tumour Infiltrating Lymphocyte (TIL) Therapy Hubs for adult patients, for the provision of Lifileucel for previously treated unresectable or metastatic melanoma, with one (1) site in the South East. Providers may only bid for one Lot. Bids submitted for multiple lots will not be considered. Bidders are to note that Providers must be located in and deliver services from the defined geographical area(s) that they are interested in providing services to. Link to NHS England Regions: NHS England " Regional teams (https://www.england.nhs.uk/about/regional-area-teams/). As a result of this procurement exercise an agreement will be established with the successful bidder(s) for a period of three (3) years with the Commissioners having the option to extend for up to an additional two (2) year(s) (maximum contract duration 5 years). The deadline for submissions is 12.00pm (noon) on Tuesday 24th June 2025. Options: Following the initial 3 year contract period, there is an option to extend for up to an additional 2 year(s) Lot 4 - South West (1 Site) The key objectives of the Procurement are to commission eight (8) Tumour Infiltrating Lymphocyte (TIL) Therapy Hubs for adult patients, for the provision of Lifileucel for previously treated unresectable or metastatic melanoma, with one (1) site in the South West. Providers may only bid for one Lot. Bids submitted for multiple lots will not be considered. Bidders are to note that Providers must be located in and deliver services from the defined geographical area(s) that they are interested in providing services to. Link to NHS England Regions: NHS England " Regional teams (https://www.england.nhs.uk/about/regional-area-teams/). As a result of this procurement exercise an agreement will be established with the successful bidder(s) for a period of three (3) years with the Commissioners having the option to extend for up to an additional two (2) year(s) (maximum contract duration 5 years). The deadline for submissions is 12.00pm (noon) on Tuesday 24th June 2025. Options: Following the initial 3 year contract period, there is an option to extend for up to an additional 2 year(s) Lot 5 - Midlands (1 Site) The key objectives of the Procurement are to commission eight (8) Tumour Infiltrating Lymphocyte (TIL) Therapy Hubs for adult patients, for the provision of Lifileucel for previously treated unresectable or metastatic melanoma, with one (1) site in the Midlands. Providers may only bid for one Lot. Bids submitted for multiple lots will not be considered. Bidders are to note that Providers must be located in and deliver services from the defined geographical area(s) that they are interested in providing services to. Link to NHS England Regions: NHS England " Regional teams (https://www.england.nhs.uk/about/regional-area-teams/). As a result of this procurement exercise an agreement will be established with the successful bidder(s) for a period of three (3) years with the Commissioners having the option to extend for up to an additional two (2) year(s) (maximum contract duration 5 years). The deadline for submissions is 12.00pm (noon) on Tuesday 24th June 2025. Options: Following the initial 3 year contract period, there is an option to extend for up to an additional 2 year(s) Lot 6 - North East and Yorkshire (1 Site) The key objectives of the Procurement are to commission eight (8) Tumour Infiltrating Lymphocyte (TIL) Therapy Hubs for adult patients, for the provision of Lifileucel for previously treated unresectable or metastatic melanoma, with one (1) site in the North East and Yorkshire. Providers may only bid for one Lot. Bids submitted for multiple lots will not be considered. Bidders are to note that Providers must be located in and deliver services from the defined geographical area(s) that they are interested in providing services to. Link to NHS England Regions: NHS England " Regional teams (https://www.england.nhs.uk/about/regional-area-teams/). As a result of this procurement exercise an agreement will be established with the successful bidder(s) for a period of three (3) years with the Commissioners having the option to extend for up to an additional two (2) year(s) (maximum contract duration 5 years). The deadline for submissions is 12.00pm (noon) on Tuesday 24th June 2025. Options: Following the initial 3 year contract period, there is an option to extend for up to an additional 2 year(s) Lot 7 - North West (1 Site) The key objectives of the Procurement are to commission eight (8) Tumour Infiltrating Lymphocyte (TIL) Therapy Hubs for adult patients, for the provision of Lifileucel for previously treated unresectable or metastatic melanoma, with one (1) site in the North West. Providers may only bid for one Lot. Bids submitted for multiple lots will not be considered. Bidders are to note that Providers must be located in and deliver services from the defined geographical area(s) that they are interested in providing services to. Link to NHS England Regions: NHS England " Regional teams (https://www.england.nhs.uk/about/regional-area-teams/). As a result of this procurement exercise an agreement will be established with the successful bidder(s) for a period of three (3) years with the Commissioners having the option to extend for up to an additional two (2) year(s) (maximum contract duration 5 years). The deadline for submissions is 12.00pm (noon) on Tuesday 24th June 2025. Options: Following the initial 3 year contract period, there is an option to extend for up to an additional 2 year(s) ## Key Details | Field | Value | | --- | --- | | Publication source | Find A Tender Service | | Latest notice | https://www.find-tender.service.gov.uk/Notice/038239-2025 | | Notice type | Tender Notice | | Procurement type | Standard | | Procurement category | Services | | Procurement method | Open | | Procurement method details | Open procedure | | Tender suitability | Not specified | | Awardee scale | Not specified | | All stages | Tender | ## Dates | Field | Value | | --- | --- | | Publication date | 8 Jul 2025 | | Submission deadline | 24 Jun 2025 | | Future notice date | Not specified | | Award date | Not specified | | Contract period | 31 Oct 2025 - 30 Oct 2030 | | Recurrence | Not specified | ## Values | Field | Value | | --- | --- | | Tender value | £69,970,000 | | Lots value | £69,910,000 | | Awards value | Not specified | | Contracts value | Not specified | ## Status | Field | Value | | --- | --- | | Tender status | Active | | Lots status | Active | | Awards status | Not specified | | Contracts status | Not specified | ## Buyer | Field | Value | | --- | --- | | Main buyer | NHS ENGLAND | | Locality | LONDON | | Post town | South East London | | Postcode | SE1 8UG | | Country | England | | ITL 1 | TLI London | | ITL 2 | TLI4 Inner London - East | | ITL 3 | TLI45 Lambeth | | Local authority | Lambeth | | Electoral ward | Waterloo & South Bank | | Westminster constituency | Vauxhall and Camberwell Green | | Delivery location | TLC North East (England), TLD North West (England), TLE Yorkshire and The Humber, TLF East Midlands (England), TLG West Midlands (England), TLH East (England), TLI London, TLJ South East (England), TLK South West (England) | ## CPV Codes ### Divisions - 85 - Health and social work services ### Codes - 85100000 - Health services ## Release History - 8 Jul 2025 at 12:43 - TenderUpdate - Tender Notice - https://www.find-tender.service.gov.uk/Notice/038239-2025 - 13 Jun 2025 at 09:25 - TenderUpdate - Tender Notice - https://www.find-tender.service.gov.uk/Notice/032160-2025 - 19 May 2025 at 07:13 - TenderUpdate - Tender Notice - https://www.find-tender.service.gov.uk/Notice/022426-2025 - 16 May 2025 at 10:57 - Tender - Tender Notice - https://www.find-tender.service.gov.uk/Notice/022156-2025 ## Notice URLs - https://health-family.force.com/s/Welcome - https://health-family.force.com/s/WelcomeShould - https://www.ardengemcsu.nhs.uk/ - https://www.england.nhs.uk/ - https://www.england.nhs.uk/about/regional-area-teams/ - https://www.england.nhs.uk/about/regional-area-teams/).Lifileucel - https://www.england.nhs.uk/wp-content/uploads/2018/08/Cancer-skin-adult.pdf - https://www.england.nhs.uk/wp-content/uploads/2018/08/Cancer-skin-adult.pdfProviders - https://www.nice.org.uk/guidance/indevelopment/gid-ta10752 - https://www.nice.org.uk/guidance/indevelopment/gid-ta10752Providers ## Provenance This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-h6vhtk-0515a8. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-h6vhtk-0515a8.json.